Scientific news

Could cannabidiol be used to treat ASIA syndrome?

With autoimmune disorders on the rise and standard treatments rendered ineffective, it might be time to look for an alternative solution, such as CBD

Marijuana stigma hurts doctor–patient relationship, study says

The fear of being labeled a "stoner" can make some patients leave painful symptoms untreated. Others may avoid the doctor entirely.

US government launches study on medical marijuana and opioid addiction

The National Institutes of Health awarded a $3.8 million grant to Albert Einstein College of Medicine and Montefiore Health System last week.

Crystal structures of agonist-bound human cannabinoid receptor CB1

The cannabinoid receptor 1 (CB1) is the principal target of the psychoactive constituent of marijuana, the partial agonist Δ9-tetrahydrocannabinol (Δ9-THC).

Zynerba Pharma's failed cannabidiol gel trial has upside for rival GW Pharma

GW Pharma’s Epidiolex could be the U.S.’s first cannabis-derived drug.

Scientists lay the groundwork for a reliable marijuana breathalyzer

NIST researchers have measured a fundamental physical property of the primary psychoactive compound in marijuana.

Is cannabidiol (CBD) safe for humans?

Studies are increasingly suggesting that CBD could be the next vital medicine for a whole host of human medical conditions

93% of patients prefer cannabis over opioids for managing pain, according to new study

A new study has investigated what patients themselves prefer when it comes to managing pain – opioids, which are widely distributed for intense pain relief, or medical marijuana.

Groundbreaking study will explore marijuana's potential as a treatment for autism

A pioneering study out of Pennsylvania will explore the effect of cannabis on children with autism. Researchers from Lehigh University plan to partner with a potential grower in the Lehigh Valley to collect quantitative data on cannabis therapy for autism.

Can cannabis chewing gum treat opioid addiction?

With drug overdoses now the leading cause of death among Americans under the age of 50, public health officials are scampering to find solutions to address the current opioid epidemic.